Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 klein2024present
%A Klein, Christian
%A Brinkmann, Ulrich
%A Reichert, Janice M.
%A Kontermann, Roland E.
%D 2024
%I Nature portfolio
%J Nature reviews drug discovery
%K
%N 4
%P 301–319
%R 10.1038/s41573-024-00896-6
%T The present and future of bispecific antibodies for cancer therapy
%V 23
@article{klein2024present,
added-at = {2024-10-30T10:11:11.000+0100},
affiliation = {Klein, C (Corresponding Author), Roche Innovat Ctr Zurich, Roche Pharm Res & Early Dev, Schlieren, Switzerland.
Kontermann, RE (Corresponding Author), Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany.
Klein, Christian, Roche Innovat Ctr Zurich, Roche Pharm Res & Early Dev, Schlieren, Switzerland.
Brinkmann, Ulrich, Roche Innovat Ctr Munich, Roche Pharm Res & Early Dev, Penzberg, Germany.
Reichert, Janice M., Antibody Soc, Framingham, MA USA.
Kontermann, Roland E., Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany.},
author = {Klein, Christian and Brinkmann, Ulrich and Reichert, Janice M. and Kontermann, Roland E.},
biburl = {https://puma.ub.uni-stuttgart.de/bibtex/2e9262642bd5b0cefbc515108347cfb9a/unibiblio},
doi = {10.1038/s41573-024-00896-6},
interhash = {989fa1c5541d2b2049ebcbc938136eff},
intrahash = {e9262642bd5b0cefbc515108347cfb9a},
issn = {{1474-1776} and {1474-1784}},
journal = {Nature reviews drug discovery},
keywords = {},
language = {eng},
number = 4,
orcid-numbers = {Brinkmann, Ulrich/0000-0002-5558-0212
Klein, Christian/0000-0001-7594-7280},
pages = {301–319},
publisher = {Nature portfolio},
research-areas = {Biotechnology & Applied Microbiology; Pharmacology & Pharmacy},
timestamp = {2024-10-30T09:11:11.000+0100},
title = {The present and future of bispecific antibodies for cancer therapy},
unique-id = {WOS:001180035900001},
volume = 23,
year = 2024
}